Skip to main navigation Skip to search Skip to main content

Inaugural Pharmacogenomics Access and Reimbursement Symposium

  • American Society of Pharmacovigilance
  • University of Patras
  • Golden Helix Foundation
  • Primary Children's Medical Center
  • Texas Tech University Health Sciences Center

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The Pharmacogenomics Access & Reimbursement Symposium, a landmark event presented by the Golden Helix Foundation and the Pharmacogenomics Access & Reimbursement Coalition, was a 1-day interactive meeting comprised of plenary keynotes from thought leaders across healthcare that focused on value-based strategies to improve patient access to personalized medicine. Stakeholders including patients, healthcare providers, industry, government agencies, payer organizations, health systems and health policy organizations convened to define opportunities to improve patient access to personalized medicine through best practices, successful reimbursement models, high quality economic evaluations and strategic alignment. Session topics included health technology assessment, health economics, health policy and value-based payment models and innovation.

Original languageEnglish
Pages (from-to)515-517
Number of pages3
JournalPharmacogenomics
Volume22
Issue number9
DOIs
StatePublished - Jun 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 9 - Industry, Innovation, and Infrastructure
    SDG 9 Industry, Innovation, and Infrastructure

Keywords

  • COVID-19
  • health economics
  • health policy
  • health technology assessment
  • innovation
  • patient access
  • payment models
  • pharmacogenetics testing
  • pharmacogenomics
  • precision medicine
  • reimbursement

Fingerprint

Dive into the research topics of 'Inaugural Pharmacogenomics Access and Reimbursement Symposium'. Together they form a unique fingerprint.

Cite this